Composite Fiber Remodels Gut Microbiota and Alleviates Dyspepsia in Adolescents
الألياف المركبة تعيد تشكيل ميكروبات الأمعاء وتخفف عسر الهضم لدى المراهقين
Journal: Frontiers in microbiology
University: Not specified
Study Type: RCT
Evidence Level: moderate
Participants: 32
Published:
⚠️ Warning: This is a preliminary study (animal/cell) and has not been proven in humans.
30-Second Summary
This pilot trial investigated the effects of a 28-day standardized composite fiber supplementation on gut microbiota and symptoms in 32 adolescents with functional dyspepsia. The double-blind, placebo-controlled study found that composite fiber remodelled the gut microbiome and showed a trend toward alleviating dyspeptic symptoms.
1-Minute Summary
Adolescent functional dyspepsia is often linked to an imbalance in intestinal microbiota. To explore targeted dietary interventions, researchers conducted a 28-day double-blind, placebo-controlled pilot trial involving 32 adolescents with functional dyspepsia. Participants were divided into a treatment group receiving 15 g/d of composite fiber and a control group receiving isoenergetic maltodextrin. Post-intervention 16S rRNA analysis revealed that composite fiber supplementation successfully remodelled the gut microbiota profile. Furthermore, the intervention demonstrated a positive trend in alleviating dyspeptic symptoms among the adolescent participants.
3-Minute Summary
This 28-day double-blind, randomized, placebo-controlled pilot trial investigated the effects of a standardized composite fiber supplementation on gut microbiota composition and dyspeptic symptoms in adolescents with functional dyspepsia (FD). Functional dyspepsia in youth is a prevalent and debilitating gastrointestinal disorder heavily intertwined with gut dysbiosis, gut-brain axis signaling, and mucosal immune activation. Dietary fibers are well-known prebiotics that resist upper gastrointestinal digestion, serving as vital substrates for colonic fermentation. This fermentation yields short-chain fatty acids (SCFAs) like acetate, propionate, and butyrate, which nourish colonocytes, reduce luminal pH, and suppress pathogenic bacterial proliferation. In this pilot study, 32 adolescent patients diagnosed with FD were randomized into two arms: a treatment group receiving 15 g/d of composite fiber (n = 15) and a control group receiving an isoenergetic maltodextrin placebo (n = 17). Following the 28-day intervention, fecal samples were harvested and subjected to 16S rRNA gene sequencing targeting the V3-V4 hypervariable regions to profile microbial shifts. The primary aims were to characterize structural alterations in the gut microbiota and evaluate trends in symptom alleviation using standardized clinical scales. The findings demonstrated that composite fiber administration successfully modulated the gut microbial architecture, driving distinct taxonomic shifts compared to the placebo cohort. Specifically, the supplementation promoted the relative abundance of beneficial taxa capable of complex carbohydrate degradation and SCFA production, while downregulating pro-inflammatory or opportunistic pathobionts commonly associated with gut mucosal irritation and aberrant fermentation. Furthermore, the trial revealed a promising clinical trend toward the alleviation of core dyspeptic symptoms—such as postprandial fullness, early satiety, and epigastric pain—in the treatment group. From a mechanistic standpoint, these results reinforce the paradigm that targeted dietary interventions can recalibrate the pediatric gut ecosystem without aggressive pharmacological agents. Adolescent FD management remains challenging due to the potential side effects of prokinetics, acid suppressants, and neuromodulators. Leveraging composite fiber offers a physiological, microbiome-targeted alternative. However, given the pilot nature of the study, the sample size (n = 32) and intervention window (28 days) necessitate cautious interpretation. Larger, multi-center, long-term randomized controlled trials with robust metabolomic integration are warranted to substantiate these findings, establish optimal dosing regimens, and elucidate precise microbe-host metabolic pathways.
Full Analysis
### Comprehensive Analysis of the Composite Fiber Pilot Trial in Adolescent Functional Dyspepsia #### 1. Introduction and Background Functional dyspepsia (FD) is a prevalent disorder of gut-brain interaction (DGBI) among adolescents, characterized by chronic or recurrent upper gastrointestinal symptoms—such as postprandial fullness, early satiety, epigastric pain, and burning—in the absence of any organic, systemic, or metabolic disease detectable by conventional diagnostic testing. The pathophysiology of adolescent FD is multifactorial, involving delayed gastric emptying, impaired gastric accommodation, visceral hypersensitivity, low-grade mucosal immune activation, and critically, gut microbiota dysbiosis. The gut microbiota modulates intestinal motility, visceral sensitivity, and neuroendocrine signaling via the gut-brain axis. Consequently, restoring microbial homeostasis has emerged as a promising therapeutic frontier. Dietary fibers exert profound prebiotic effects, stimulating the growth of health-promoting taxa and generating short-chain fatty acids (SCFAs). However, high-quality, targeted clinical trials investigating standardized composite fiber interventions in pediatric and adolescent populations remain scarce. This pilot study sought to bridge this gap by evaluating the microbial and symptomatic impact of composite fiber supplementation in adolescents with FD. #### 2. Methodology and Study Design - **Trial Design:** A 28-day, double-blind, randomized, placebo-controlled pilot trial. - **Participant Cohort:** Thirty-two adolescent patients diagnosed with functional dyspepsia according to standard clinical criteria. - **Interventions:** - *Treatment Group (n = 15):* Received 15 g/d of a standardized composite fiber supplement. - *Control Group (n = 17):* Received an isoenergetic maltodextrin placebo to control for caloric and structural confounders. - **Microbiological Analysis:** Fecal samples collected post-intervention underwent high-throughput 16S rRNA gene sequencing targeting the V3-V4 hypervariable regions. This sequencing depth allowed for comprehensive profiling of bacterial community richness, diversity indices (alpha and beta diversity), and relative taxonomic abundances. - **Clinical Endpoint Assessment:** Evaluation of dyspeptic symptom alleviation trends using standardized questionnaires and clinical scoring systems. #### 3. Results and Microbial Dynamics - **Microbial Composition Shifts:** The 16S rRNA sequencing data revealed that 28 days of composite fiber supplementation induced notable modifications in gut microbial architecture. While baseline differences were controlled, post-intervention profiles demonstrated divergent clustering between the treatment and control cohorts. - **Taxonomic Enrichment:** The composite fiber group exhibited a selective proliferation of saccharolytic taxa—specifically specialized in fermenting complex polysaccharides into vital metabolites like acetate, propionate, and butyrate. Concurrently, there was a relative reduction in opportunistic pathobionts that thrive on protein fermentation or mucosal inflammation. - **Symptom Trends:** Clinical evaluation revealed a positive trend toward the alleviation of core dyspeptic symptoms (postprandial distress and epigastric pain syndromes) in the adolescent patients receiving the composite fiber, highlighting a parallel between microbial restoration and clinical improvement. #### 4. Mechanistic Interpretation The observed clinical trends are tightly bound to microbial fermentation pathways. When composite fibers reach the colon undigested, they act as selective energy sources for beneficial commensal bacteria. The resulting elevation in SCFAs exerts multiple localized and systemic effects: it decreases luminal pH (inhibiting acid-sensitive pathogens), strengthens intestinal epithelial tight junctions (reducing gut permeability and low-grade mucosal immune activation), and modulates enteric nervous system signaling via free fatty acid receptors (FFAR2 and FFAR3). In adolescents, whose gut ecosystems are highly dynamic and responsive to dietary shifts, targeted fiber delivery provides a physiological mechanism to dampen visceral hypersensitivity and improve gastrointestinal motility without pharmacological intervention. #### 5. Limitations - **Sample Size:** With a total of 32 participants (n = 15 and n = 17), the study is underpowered for broad generalization, reflecting its pilot nature. - **Duration:** The 28-day intervention window captures short-term adaptation and microbial shifts, but long-term sustainability and durability of symptom relief remain unaddressed. - **Methodological Constraints:** 16S rRNA V3-V4 sequencing provides taxonomic resolution predominantly down to the genus level; functional profiling inferred from marker genes lacks the metabolic granularity of shotgun metagenomics or direct metabolomic quantification of SCFAs. - **Dietary Control:** While placebo-controlled, background free-living adolescent diets were not strictly clamped, introducing potential confounding nutritional variability.Health Implications
Dietary fiber is essential for cultivating a resilient, diverse gut microbiome by fueling beneficial short-chain fatty acid-producing bacteria. Integrating varied fiber sources—such as oats, legumes, vegetables, and whole grains—into daily adolescent nutrition supports gastrointestinal comfort, reinforces the gut mucosal barrier, and optimizes gut-brain axis communication.
Key Findings
- Composite fiber supplementation significantly remodels the gut microbiota composition in adolescents with functional dyspepsia.
- The 28-day intervention showed a promising trend toward alleviating dyspeptic symptoms compared to the control group.